Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Crystal structure of the Lin28-interacting module of human terminal uridylyltransferase that regulates let-7 expression.

Yamashita S, Nagaike T, Tomita K.

Nat Commun. 2019 Apr 29;10(1):1960. doi: 10.1038/s41467-019-09966-5.

2.

G-Protein Coupled Receptor Protein Synthesis on a Lipid Bilayer Using a Reconstituted Cell-Free Protein Synthesis System.

Gessesse B, Nagaike T, Nagata K, Shimizu Y, Ueda T.

Life (Basel). 2018 Nov 2;8(4). pii: E54. doi: 10.3390/life8040054.

3.

[Cell-free translation system: Development in biochemistry and advance in synthetic biology].

Kanamori T, Nagaike T, Kuruma Y, Amikura K, Ueda T.

Seikagaku. 2017 Apr;89(2):211-20. Review. Japanese. No abstract available.

PMID:
29625004
4.

Crystal structures of U6 snRNA-specific terminal uridylyltransferase.

Yamashita S, Takagi Y, Nagaike T, Tomita K.

Nat Commun. 2017 Jun 7;8:15788. doi: 10.1038/ncomms15788.

5.

Synthetic mRNA devices that detect endogenous proteins and distinguish mammalian cells.

Kawasaki S, Fujita Y, Nagaike T, Tomita K, Saito H.

Nucleic Acids Res. 2017 Jul 7;45(12):e117. doi: 10.1093/nar/gkx298.

6.

Human BCDIN3D monomethylates cytoplasmic histidine transfer RNA.

Martinez A, Yamashita S, Nagaike T, Sakaguchi Y, Suzuki T, Tomita K.

Nucleic Acids Res. 2017 May 19;45(9):5423-5436. doi: 10.1093/nar/gkx051.

7.

[An expanding network links transcription and mRNA 3' processing].

Nagaike T.

Seikagaku. 2014 Feb;86(1):77-80. Review. Japanese. No abstract available.

PMID:
24693703
8.

In vitro analysis of transcriptional activators and polyadenylation.

Nagaike T, Manley JL.

Methods Mol Biol. 2014;1125:65-74. doi: 10.1007/978-1-62703-971-0_6.

PMID:
24590780
9.

Transcriptional activators enhance polyadenylation of mRNA precursors.

Nagaike T, Manley JL.

RNA Biol. 2011 Nov-Dec;8(6):964-7. doi: 10.4161/rna.8.6.17210. Epub 2011 Nov 1.

10.

Transcriptional activators enhance polyadenylation of mRNA precursors.

Nagaike T, Logan C, Hotta I, Rozenblatt-Rosen O, Meyerson M, Manley JL.

Mol Cell. 2011 Feb 18;41(4):409-18. doi: 10.1016/j.molcel.2011.01.022.

11.

Mechanism for the alteration of the substrate specificities of template-independent RNA polymerases.

Toh Y, Takeshita D, Nagaike T, Numata T, Tomita K.

Structure. 2011 Feb 9;19(2):232-43. doi: 10.1016/j.str.2010.12.006.

12.

Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex.

Xiang K, Nagaike T, Xiang S, Kilic T, Beh MM, Manley JL, Tong L.

Nature. 2010 Oct 7;467(7316):729-33. doi: 10.1038/nature09391. Epub 2010 Sep 22.

13.

The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors.

Rozenblatt-Rosen O, Nagaike T, Francis JM, Kaneko S, Glatt KA, Hughes CM, LaFramboise T, Manley JL, Meyerson M.

Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):755-60. doi: 10.1073/pnas.0812023106. Epub 2009 Jan 9.

14.

Polyadenylation in mammalian mitochondria: insights from recent studies.

Nagaike T, Suzuki T, Ueda T.

Biochim Biophys Acta. 2008 Apr;1779(4):266-9. doi: 10.1016/j.bbagrm.2008.02.001. Epub 2008 Feb 14. Review.

PMID:
18312863
15.
16.

Decreased CCA-addition in human mitochondrial tRNAs bearing a pathogenic A4317G or A10044G mutation.

Tomari Y, Hino N, Nagaike T, Suzuki T, Ueda T.

J Biol Chem. 2003 May 9;278(19):16828-33. Epub 2003 Mar 5.

Supplemental Content

Loading ...
Support Center